Literature DB >> 35093069

Correction to: Co-prevalence of human Papillomaviruses (HPV) and Epstein-Barr virus (EBV) in healthy blood donors from diverse nationalities in Qatar.

Ishita Gupta1, Gheyath K Nasrallah2, Anju Sharma1, Ayesha Jabeen1, Maria K Smatti2, Hamda A Al-Thawadi1, Ali A Sultan3, Moussa Alkhalaf4, Semir Vranic5, Ala-Eddin Al Moustafa6,7.   

Abstract

Entities:  

Year:  2022        PMID: 35093069      PMCID: PMC8801089          DOI: 10.1186/s12935-022-02459-4

Source DB:  PubMed          Journal:  Cancer Cell Int        ISSN: 1475-2867            Impact factor:   5.722


× No keyword cloud information.

Correction to: Cancer Cell Int (2020) 20:107 https://doi.org/10.1186/s12935-020-01190-2

In this article [1], there was a copy pasting error of the PCR image of the representative data provided in Figures 1 and 2. The corrected figures are published with this erratum (Figs. 1 and 2).
Fig. 1

Representative PCR for low-risk HPV-subtypes in 15 different EBV-positive and EBV-negative healthy blood donors

Fig. 2

Representative PCR for high-risk HPV-subtypes in 15 different EBV-positive and EBV-negative samples of healthy blood donors

Representative PCR for low-risk HPV-subtypes in 15 different EBV-positive and EBV-negative healthy blood donors Representative PCR for high-risk HPV-subtypes in 15 different EBV-positive and EBV-negative samples of healthy blood donors
  1 in total

1.  Co-prevalence of human Papillomaviruses (HPV) and Epstein-Barr virus (EBV) in healthy blood donors from diverse nationalities in Qatar.

Authors:  Ishita Gupta; Gheyath K Nasrallah; Anju Sharma; Ayesha Jabeen; Maria K Smatti; Hamda A Al-Thawadi; Ali A Sultan; Moussa Alkhalaf; Semir Vranic; Ala-Eddin Al Moustafa
Journal:  Cancer Cell Int       Date:  2020-04-03       Impact factor: 5.722

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.